A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 117
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ER
Long Form : estradiol receptor
No. Year Title Co-occurring Abbreviation
2019 1,2,4-Oxadiazole-5-ones as analogues of tamoxifen: synthesis and biological evaluation. TAM
2019 Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells. AR, CRPC, EMT, PC, SST, SSTRs
2018 Effects of calcium and estrogen on the development of the ceratohyal cartilage in zebrafish (Danio rerio) larvae upon embryo and maternal cadmium exposure. CH, F-Cd
2018 Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications. PC
2018 Hormone-dependent medial preoptic/lumbar spinal cord/autonomic coordination supporting male sexual behaviors. AR, DHT
2014 17beta-Estradiol induces supernumerary primordial germ cells in embryos of the polychaete Platynereis dumerilii. ICI, PGCs
2014 Buyang Huanwu Decoction () reduces infarct volume and enhances estradiol and estradiol receptor concentration in ovariectomized rats after middle cerebral artery occlusion. MCAO
2014 Lentivirus vector-mediated mitofusin-2 overexpression in rat ovary changes endocrine function and promotes follicular development in vivo. FSH, FSHR, GFP, LH, LHR, PR, rMfn2
2013 Lipopolysaccharide-induced modulation in the expression of progesterone receptor and estradiol receptor leads to early pregnancy loss in mouse. LPS, PCR, PR
10  2012 Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers. PR
11  2011 Interplay between steroid receptors and neoplastic progression in sarcoma tumors. AR, EGF, EGFR
12  2010 Proliferation of human mammary cancer cells exposed to 27-hydroxycholesterol. ---
13  2009 [Study on the underlying mechanism of acupuncture in regulating neuroendocrine activity in dysmenorrhea rats]. ELI, FSH, GnRH, GnRHR, LH, PR
14  2008 Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus. SERMs
15  2008 [Regulatory effect of Ningxin Hongqi Capsule on local ovarian autocrine and paracrine factors in rats during peri-menopausal period]. ACT, FS, FSH, INH-alpha, LH, PR
16  2007 Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model. PR
17  2007 Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide. ---
18  2007 Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites. 5alphaP
19  2007 The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. PgR
20  2007 [Experimental study on Ruxian Pill I in treating mammary gland hyperplasia rabbits]. MGH, PR, RXP I, XYP
21  2005 Prostatic cancer/benign prostatic hypertrophy. Subcellular distribution of estradiol/androgen receptors. AR, BPH, PCa, PM
22  2005 Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables. APAAP, FNABs, LNS
23  2005 Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP. CREB, egr-1, ERE, TH
24  2004 Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer. AC, SN, SNB
25  2003 A multiparametric study of the action of mifepristone used in emergency contraception using the Rhesus monkey as a primate model. EC, LIF, PP14, PR, VEGF
26  2003 Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies. PR
27  2003 Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance. MPA, NOR, PR
28  2003 mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen. PgR
29  2003 Role of estradiol-17beta on nuclear and cytoplasmic maturation of pig oocytes. FPN, MPN
30  2002 The glucocorticoid receptor represses the positive autoregulation of the trout estrogen receptor gene by preventing the enhancer effect of a C/EBPbeta-like protein. GR, rt
31  2002 [Effects of progestins on human endometrium in vitro]. MPA, NOR, PGF2 alpha, PR
32  2001 17 beta-estradiol increases Ca(2+) influx and down regulates interleukin-2 receptor in mouse thymocytes. PHA
33  2001 Aryl hydrocarbon receptor (AhR)-linked inhibition of luteal cell progesterone secretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin treated cells. AhR, TCDD
34  2001 Differential expression of estradiol receptors alpha and beta by gonadotropes during the estrous cycle. FSH, LH
35  2001 Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up. EGFR
36  2001 Nongenomic mechanism mediates estradiol stimulation of axon growth in male rat hypothalamic neurons in vitro. ---
37  2001 [Effect and mechanism study of kidney tonifying and blood circulation activating Chinese drugs on development of mammary glands in female juvenile rats]. GH, PR
38  2001 [Effects of kidney reinforcing and blood circulation activating Chinese medicine on morphological structure of mammary glands in models of mammary atrophy and hyperplasia in female rats]. PR
39  2000 Endometrial response to sexual steroids as assessed by prostaglandin F(2alpha) output in explant culture and hormone receptor expression. PG, PR
40  2000 Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. EGFR, HPG, PgR, RR, RT-PCR
41  1999 In vitro responses to 17beta-estradiol throughout pubertal maturation in female human bone cells. ALP, hOBs, PR
42  1999 Role of estradiol receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. AhR, CYP1A1, CYP1B1, PAI-2, TCDD, XRE
43  1998 Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants. VDR
44  1998 Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers. HPG, PgR, uPA
45  1998 [Study on mechanism of bushen yugong granule in treating uterine dysgenesia]. PR
46  1998 [Study on relationship between ovulation inducing effect of drug-acupuncture and endometrial contents of estradiol receptor and progesterone receptor]. PR
47  1997 Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. BC, DFS, EGFR, ER and PR, NO, OS
48  1996 Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice. CL
49  1996 Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification. BC, CD, EGFR
50  1996 Synergistic and antagonistic interactions between docetaxel and interferon-beta on growth of human breast cancer cells in vitro. IFN-beta
51  1996 [Effects of levonorgestrel subdermal implants on estradiol and progesterone receptors of endometrium and ovarian tissues in rats]. LNG, PR
52  1995 A comparison of LH secretion and brain estradiol receptors in heterosexual and homosexual rams and female sheep. AMY, AP, HYP, POA
53  1995 Binding of estradiol to whole prostatic DU-145 cells in the presence and absence of tamoxifen and acetylsalicylic acid. ---
54  1995 Contrasting effects of tamoxifen and ICI 182 780 on estrogen-induced calbindin-D 9k gene expression in the uterus and in primary culture of myometrial cells. TAM
55  1995 Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. AhR, CYP1A1, EROD, PAI-2, RT-PCR, TCDD
56  1995 [Different patterns of follicular development and luteal function]. LPD, LUFS, ONF, OSF, PCO, PR
57  1994 Immuno-electron microscopic localization of estradiol receptor in cells of male and female reproductive and non-reproductive organs. ---
58  1994 [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma]. Fote
59  1993 Regulation of phospholipid turnover by steroid hormones in endometrial carcinoma and breast cancer cells. PR
60  1993 Short term treatment of tamoxifen and estradiol on estradiol and progesterone receptors in rabbit uterus. PR, PRn, TAM
61  1992 Absence of direct regulation of prolactin cells by estradiol-17 beta in rainbow trout (Oncorhynchus mykiss). PRL, rtER
62  1992 Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival. CD
63  1992 CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus. ---
64  1992 Characterization of an estradiol-independent but estradiol-responsive growth phenotype in a human endometrial adenocarcinoma heterotransplanted into nude mice. PgR
65  1992 Effect of neonatal pineal ablation on estradiol receptors in mammary glands of rats housed under varying photoperiods. ---
66  1991 Immunoelectron microscopic localization of estrogen receptor on pre-mRNA containing constituents of rat uterine cell nuclei. RNP
67  1991 In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor. ---
68  1991 [Cancer of the breast and the receptor status]. DCC, EIA, PR
69  1990 Hydroxylated triphenylacrylonitriles adopt a unique orientation within the binding site of the estrogen receptor. TPEs
70  1989 Altered estrogen receptor system in estrogen-unresponsive human endometrial adenocarcinoma cells. FASA
71  1989 Estradiol receptor-nuclear interactions in aging mouse uteri: the role of DNA and nuclear matrix. NM
72  1989 Hormone receptor status in human endometrial adenocarcinoma. ERc, PR, PRc, PRn
73  1989 Metal binding sites of the estradiol receptor from calf uterus and their possible role in the regulation of receptor function. ---
74  1988 Changes in the hormone dependency of DMBA-induced rat mammary tumors with reference to the effect of tamoxifen. PgR
75  1988 Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer. LDH, PR
76  1988 In vitro interaction of estradiol receptor with Ca2+-calmodulin. CaM
77  1988 Patterns of estrogen and progesterone receptors in rhesus monkey endometrium during secretory phase of normal menstrual cycle and preimplantation stages of gestation. PgR
78  1988 Quality control study of estradiol and progesterone receptor determination. Brno, PR
79  1988 Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. cis-4OHTAM, HBE, TAM, trans-4OHTAM
80  1988 [Gonadotropin-releasing hormone receptors in human breast cancer tissue]. GnRH, PR
81  1987 Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies. PR
82  1987 Progesterone receptor activity and the response to the first endocrine therapy in advanced breast cancer. PgR
83  1987 Subunit composition of the molybdate-stabilized "8-9 S" nontransformed estradiol receptor purified from calf uterus. hsp 90
84  1987 The distribution and prognostic implications of steroid receptors in endometrial carcinomas. PR
85  1987 The influence of progestins on receptor levels in breast cancer metastasis. AR, HD, MA, MPA, PgR
86  1987 [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas]. PR
87  1986 Different interaction of estradiol and antiestrogens with the estrogen receptor of rat uterus. ---
88  1986 Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies. ---
89  1986 Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. DCC, iER, SII
90  1986 Relationships of steroid hormone receptors, age and histological characteristics in human breast cancer. PR
91  1986 Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors. PA, PR, tPA
92  1986 [Estradiol and progesterone receptors in DMBA-induced mammary neoplasms in rats under cyclic hormonal exposures]. HPC, PR, TS
93  1985 Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency. PR
94  1985 Factors associated with prognosis in human breast cancer. V. The simultaneous use of estrogen and progesterone receptor measurements for prediction of short-term relapse. PgR
95  1985 Prediction of biological behaviour of human breast cancer using multiple parameters. A preliminary study. BBF, BVI, PA, PgR, PRA
96  1985 Quality control study for estradiol receptor determination. DCC
97  1985 Relationship between peroxidase activity and steroid receptors in human mammary tumors. PA, PgR
98  1983 A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. DCC, IF, PgR
99  1983 Androgen receptors in rat and human prostate. AR, RVP, SBP
100  1983 Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level. PR